The Price of Cocaine, Heroin and Marijuana, 1981–1993

AuthorRaymond Hyatt,Paul Scheiman,William Rhodes
Date01 July 1994
DOI10.1177/002204269402400302
Published date01 July 1994
Subject MatterArticle
The Journal of Drug Issues 24(3), 383-402 1994
THE PRICE OF COCAINE, HEROIN AND MARIJUANA,
1981-1993
William
Rhodes
Raymond
Hyatt
Paul
Scheiman
The analysis reported in this article provides a consistent price series for
cocaine. heroin, and marijuana based on over twelve years
of
data from the
Drug Enforcement Administration's System to Retrieve Information from
Drug Evidence (STRIDE). Cocaine and heroin prices fell sharply through
most
of
the 1980s, but seem to have stabilized in the early I 990s. In
contrast, marijuana prices rose markedly through most
of
the 1980s, but
seem to havefallen in 1992 and 1993.
Prices
of illicit drugs vary widely over time, from place to place, and even
from transaction to transaction. This variation is important to monitor because
trends in drug prices are an indicator of the success of national policies to reduce
the availability of illicit substances. Furthermore, the relationship between illicit
drug prices and drug use is an important research topic, whose study is hindered
by the lack of suitable price series for cocaine, heroin and marijuana.
For
example, we have used price series similar to those described in this
article to show that the consumption of cocaine by heavy users is sensitive to its
price (Hyatt and Rhodes n.d.) and that recent decreases in the price of heroin have
been associated with an increased rate of insufflation of heroin (Hunt and Rhodes
1993). Others have used their own price series to analyze the relationship
between heroin prices and crime (Brown and Silverman 1974), cocaine prices and
consumption decisions by high school students (DiNardo 1992), and price mark-
ups across illicit drug distribution networks (Caulkins and Padman 1993).
This essay discusses some reasons why trends in illicit drug prices are difficult
to measure. It advances methods to overcome these difficulties and provides
national and representative local estimates of trends in prices of cocaine, heroin,
and marijuana from 1981 through the first quarter of 1993.
WilliamRhodes, Ph.D., is an expert in
quantitative
analysis
and
computer
applications.
Trained
in
econometrics,
he has
taught
graduate-level
applied
statistics
at two
universities
andhas beensenior
scientist
at Abt
Associates
since
1988.
He is a past
research
directorat the U.S.
Sentencing
Commission,
senior
economist
at the
Institute
for Law
and
Social
Research.
and
assistant
professor
at
Florida
State
Universiry.
RaymondR. Hyall, Jr. is a senior
analyst
at Abt
Associates.
He has eight years
experience
teaching
both
mathematics
and
computer
science
at the
college
level.has served as chair of a
computer
science
department,
andwas
consulting
senior
research
methodologist
in the
Centerfor
Applied
Social
Research
at
Northeastern
University.
Paul M. Scheiman has
worked
on Abt's
contract
with the Office of
National
Drug
Control
Policy
(ONDCP)
since
1990.
He
analyzed
the data for a
forthcoming
National
Institute
of Justice report. Send reprint
requests
to
William
Rhodes,
Ph.D., ABT
Associates
lnc., 55
Wheeler
Street,
Cambridge,
MA
02138.
©Journal of Drug Issues, Inc. 002-0426/94/03/383-402 $1.00
383
RHODES, HYATT, SCHEIMAN
Problems in Determining the Market Price for Illicit Drugs
The principal difficulties when estimating the market prices of cocaine, heroin,
and marijuana are similar to those when estimating prices in any illegal market.
Transactions are clandestine; there are few advertised prices, and market surveys
sponsored by groups representing the interest of dealers or buyers are rare.
Information about prices comes from researchers and police who observe drug
transactions and sometimes make drug buys. The data in this analysis result from
drug purchases reported in the Drug Enforcement Administration's System to
Retrieve Information from Drug Evidence (STRIDE).
STRIDE reports the prices paid by Drug Enforcement Administration (DEA)
agents (as well as other federal agents and some state agents) for cocaine, heroin,
and marijuana. These prices vary depending on the amount of drug purchased;
obviously, larger transactions have higher costs. Illicit drugs also vary in quality.
Although quality has many dimensions, the most important for buyers and sellers
is the drug's purity - the amount of pure cocaine or heroin contained in a
purchase exclusive of diluents. In the case of marijuana, it is the amount of the
chemical THC. Therefore, to afford meaningful comparisons when bulk amounts
and purities vary widely, calculations are based on price
per
pure gram for
cocaine and heroin, and price per bulk gram for marijuana. 1
However, the price per pure gram also varies with distribution level. Retail
buyers pay more per pure unit of drug than retailers pay to wholesalers, and
retailers pay more per unit of drug than wholesalers pay to importers. To monitor
prices over time and across cities, prices must be compared at equivalent
distribution levels. Because they are not readily identified in the STRIDE data,
distribution levels have been inferred from the amount of drug exchanged - pure
amount for cocaine and heroin and bulk amount for marijuana.
This method of identifying distribution levels is imperfect, because the multiple
distributions levels have no clear demarkation. Nevertheless, transactions greater
than some specified threshold for each drug type are unlikely to be retail
purchases. For example, it is unlikely that a transaction of five ounces or more of
pure cocaine occurs at the retail level, while it is likely that a high percentage of
cocaine transactions involving less thanone pure gram are retail-level transactions.
Average prices based on data truncated at a selected threshold are imperfect
reflections of prices paid at retail, however. Any threshold that affords a
sufficient number of observations to support the computation of reliable estimates
will necessarily mix transactions from different distribution levels. That is, from
period to period, the sample of transactions will contain varying percentages of
sales at the retail and wholesale levels, and apparent price trends will be sensitive
to changes in this overlap. In one year more purchases may have been in the
upper range of transaction sizes, where price per pure gram tends to be relatively
low. In another year, purchases may have been at the lower end of the range,
where price per pure gram tends to be relatively high. Thus, observed changes in
average prices from one year to the next may arise from differences in transaction
levels represented in the data rather than from changes in prices.
A second approach to taking the distribution level into account is to use
regression analysis to control for the distribution level when estimating prices.
Later, we describe a regression-based approach that we used to estimate a
standardized price for cocaine, heroin, and marijuana. The standardized price is
the price per pure gram (bulk for marijuana) assuming a fixed transaction size.
The reported standardized price of cocaine is the estimated average price per pure
384 JOURNAL OF DRUG ISSUES

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT